Technology
Health
Biotechnology

InVivo Therapeutics

$1.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-7.38%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NVIV and other stocks, options, ETFs, and crypto commission-free!

About

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. Read More The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.

Employees
6
Headquarters
Cambridge, Massachusetts
Founded
2005
Market Cap
10.52M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
157.90K
High Today
$1.23
Low Today
$1.13
Open Price
$1.20
Volume
25.73K
52 Week High
$7.60
52 Week Low
$1.12

Collections

Technology
Health
Biotechnology
Medical
Therapy
2015 IPO
US
North America

Earnings

-$3.34
-$1.85
-$0.37
$1.12
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.29 per share
Actual
$1.12 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.